GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Sale Of Property, Plant, Equipment

Biosergen AB (OSTO:BIOSGN) Sale Of Property, Plant, Equipment : kr0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Sale Of Property, Plant, Equipment?

Biosergen AB's sale of property, plant, equipment for the three months ended in Sep. 2024 was kr0.00 Mil. It means Biosergen AB gained kr0.00 Mil from selling property, plant, and equipment. Biosergen AB's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Jun. 2024 ), Biosergen AB gained the same money from selling property, plant, and equipment in Sep. 2024 (kr0.00 Mil).


Biosergen AB Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Biosergen AB's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosergen AB Sale Of Property, Plant, Equipment Chart

Biosergen AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Sale Of Property, Plant, Equipment
- - - -

Biosergen AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biosergen AB Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosergen AB Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Biosergen AB's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosergen AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Fogdevreten 2, Solna, SWE, 17165
Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB Headlines

No Headlines